GMED logo

Globus Medical (GMED) EBITDA

annual EBITDA:

$473.73M+$127.14M(+36.68%)
December 31, 2024

Summary

  • As of today (May 29, 2025), GMED annual EBITDA is $473.73 million, with the most recent change of +$127.14 million (+36.68%) on December 31, 2024.
  • During the last 3 years, GMED annual EBITDA has risen by +$209.00 million (+78.95%).
  • GMED annual EBITDA is now at all-time high.

Performance

GMED EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGMEDincome statement metrics

quarterly EBITDA:

$164.13M+$18.85M(+12.98%)
March 31, 2025

Summary

  • As of today (May 29, 2025), GMED quarterly EBITDA is $164.13 million, with the most recent change of +$18.85 million (+12.98%) on March 31, 2025.
  • Over the past year, GMED quarterly EBITDA has increased by +$79.32 million (+93.52%).
  • GMED quarterly EBITDA is now at all-time high.

Performance

GMED quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGMEDincome statement metrics

TTM EBITDA:

$553.07M+$79.32M(+16.74%)
March 31, 2025

Summary

  • As of today (May 29, 2025), GMED TTM EBITDA is $553.07 million, with the most recent change of +$79.32 million (+16.74%) on March 31, 2025.
  • Over the past year, GMED TTM EBITDA has increased by +$197.55 million (+55.56%).
  • GMED TTM EBITDA is now at all-time high.

Performance

GMED TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGMEDincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

GMED EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+36.7%+93.5%+55.6%
3 y3 years+79.0%+150.4%+114.0%
5 y5 years+106.4%+276.8%+147.9%

GMED EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+79.0%at high+150.4%at high+114.0%
5 y5-yearat high+165.6%at high+1707.8%at high+252.1%
alltimeall timeat high+386.9%at high+1707.8%at high+1937.3%

GMED EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
$164.13M(+13.0%)
$553.07M(+16.7%)
Dec 2024
$473.73M(+36.7%)
$145.28M(+25.3%)
$473.76M(+11.3%)
Sep 2024
-
$115.94M(-9.2%)
$425.59M(+7.5%)
Jun 2024
-
$127.71M(+50.6%)
$395.99M(+11.4%)
Mar 2024
-
$84.82M(-12.7%)
$355.53M(+2.6%)
Dec 2023
$346.58M(+13.8%)
$97.12M(+12.5%)
$346.58M(+5.6%)
Sep 2023
-
$86.34M(-1.0%)
$328.20M(+3.0%)
Jun 2023
-
$87.25M(+15.0%)
$318.48M(+1.2%)
Mar 2023
-
$75.87M(-3.6%)
$314.83M(+3.4%)
Dec 2022
$304.50M(+15.0%)
$78.73M(+2.7%)
$304.50M(+13.3%)
Sep 2022
-
$76.63M(-8.3%)
$268.69M(+2.1%)
Jun 2022
-
$83.60M(+27.5%)
$263.11M(+1.8%)
Mar 2022
-
$65.55M(+52.7%)
$258.39M(-2.4%)
Dec 2021
$264.73M(+48.4%)
$42.92M(-39.6%)
$264.73M(-11.5%)
Sep 2021
-
$71.05M(-9.9%)
$299.22M(+1.2%)
Jun 2021
-
$78.88M(+9.7%)
$295.75M(+43.1%)
Mar 2021
-
$71.89M(-7.1%)
$206.67M(+15.9%)
Dec 2020
$178.35M(-22.3%)
$77.41M(+14.6%)
$178.35M(+6.9%)
Sep 2020
-
$67.58M(-761.9%)
$166.85M(+6.2%)
Jun 2020
-
-$10.21M(-123.4%)
$157.09M(-29.6%)
Mar 2020
-
$43.56M(-33.9%)
$223.14M(-2.8%)
Dec 2019
$229.49M(+5.0%)
$65.92M(+14.0%)
$229.49M(+2.0%)
Sep 2019
-
$57.82M(+3.6%)
$225.02M(+4.1%)
Jun 2019
-
$55.83M(+11.9%)
$216.23M(-0.6%)
Mar 2019
-
$49.91M(-18.8%)
$217.49M(-2.4%)
Dec 2018
$218.51M(+6.4%)
$61.46M(+25.3%)
$222.84M(+2.0%)
Sep 2018
-
$49.03M(-14.1%)
$218.41M(+1.2%)
Jun 2018
-
$57.09M(+3.3%)
$215.84M(+4.1%)
Mar 2018
-
$55.26M(-3.1%)
$207.41M(+1.0%)
DateAnnualQuarterlyTTM
Dec 2017
$205.39M(+6.4%)
$57.03M(+22.8%)
$205.39M(+2.2%)
Sep 2017
-
$46.46M(-4.5%)
$200.90M(+0.3%)
Jun 2017
-
$48.66M(-8.6%)
$200.34M(+2.0%)
Mar 2017
-
$53.24M(+1.3%)
$196.44M(+1.8%)
Dec 2016
$192.99M(-1.3%)
$52.55M(+14.5%)
$192.99M(-4.8%)
Sep 2016
-
$45.90M(+2.6%)
$202.69M(-0.4%)
Jun 2016
-
$44.76M(-10.1%)
$203.47M(+0.8%)
Mar 2016
-
$49.79M(-20.0%)
$201.81M(+3.2%)
Dec 2015
$195.59M(+22.6%)
$62.24M(+33.3%)
$195.59M(+9.7%)
Sep 2015
-
$46.68M(+8.3%)
$178.29M(+3.9%)
Jun 2015
-
$43.10M(-1.1%)
$171.60M(+3.6%)
Mar 2015
-
$43.57M(-3.1%)
$165.58M(+3.8%)
Dec 2014
$159.59M(+32.0%)
$44.95M(+12.4%)
$159.59M(+20.0%)
Sep 2014
-
$39.99M(+7.9%)
$133.02M(+4.3%)
Jun 2014
-
$37.07M(-1.4%)
$127.49M(+2.3%)
Mar 2014
-
$37.58M(+104.5%)
$124.62M(+3.1%)
Dec 2013
$120.93M(-8.9%)
$18.38M(-46.7%)
$120.93M(-11.6%)
Sep 2013
-
$34.46M(+0.8%)
$136.85M(+2.1%)
Jun 2013
-
$34.20M(+0.9%)
$134.09M(+0.2%)
Mar 2013
-
$33.89M(-1.2%)
$133.83M(+0.9%)
Dec 2012
$132.68M(+14.6%)
$34.30M(+8.2%)
$132.68M(+3.4%)
Sep 2012
-
$31.70M(-6.6%)
$128.31M(+0.7%)
Jun 2012
-
$33.93M(+3.6%)
$127.46M(+5.0%)
Mar 2012
-
$32.75M(+9.4%)
$121.39M(+4.8%)
Dec 2011
$115.78M(+9.6%)
$29.93M(-3.0%)
$115.80M(+34.9%)
Sep 2011
-
$30.86M(+10.7%)
$85.87M(+56.1%)
Jun 2011
-
$27.86M(+2.6%)
$55.01M(+102.6%)
Mar 2011
-
$27.15M
$27.15M
Dec 2010
$105.67M(+8.6%)
-
-
Dec 2009
$97.30M
-
-

FAQ

  • What is Globus Medical annual EBITDA?
  • What is the all time high annual EBITDA for Globus Medical?
  • What is Globus Medical annual EBITDA year-on-year change?
  • What is Globus Medical quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Globus Medical?
  • What is Globus Medical quarterly EBITDA year-on-year change?
  • What is Globus Medical TTM EBITDA?
  • What is the all time high TTM EBITDA for Globus Medical?
  • What is Globus Medical TTM EBITDA year-on-year change?

What is Globus Medical annual EBITDA?

The current annual EBITDA of GMED is $473.73M

What is the all time high annual EBITDA for Globus Medical?

Globus Medical all-time high annual EBITDA is $473.73M

What is Globus Medical annual EBITDA year-on-year change?

Over the past year, GMED annual EBITDA has changed by +$127.14M (+36.68%)

What is Globus Medical quarterly EBITDA?

The current quarterly EBITDA of GMED is $164.13M

What is the all time high quarterly EBITDA for Globus Medical?

Globus Medical all-time high quarterly EBITDA is $164.13M

What is Globus Medical quarterly EBITDA year-on-year change?

Over the past year, GMED quarterly EBITDA has changed by +$79.32M (+93.52%)

What is Globus Medical TTM EBITDA?

The current TTM EBITDA of GMED is $553.07M

What is the all time high TTM EBITDA for Globus Medical?

Globus Medical all-time high TTM EBITDA is $553.07M

What is Globus Medical TTM EBITDA year-on-year change?

Over the past year, GMED TTM EBITDA has changed by +$197.55M (+55.56%)
On this page